Nola Masterson is Managing Director of Science Futures LLC. Science Futures is a 26 year old investment and advisory firm. Ms. Masterson is a biotechnology industry leader and forward thinker with more than 32 years of business experience in the life sciences industry and in venture capital investment. From 2000 to 2005, she was a Venture Partner with TVM Capital GmbH, one of the first and largest venture capital firms in Germany. She was a co-founder and President of Sequenom, Inc., a DNA sequencing company which went public on Nasdaq in 2000, and wrote the first business plans for IDEC and Insight Vision, as a consultant to Kleiner Perkins Caufield & Byers, and for ReSound, with Dr. Rodney Perkins, the founder of ReSound. She was the first biotech analyst on Wall Street for Drexel Burnham and Merrill Lynch.
Ms. Masterson is a member of the Board of Directors of Repros Therapeutics Inc. (RPRX) and Generex Biotechnology Corporation (GNBT), both Nasdaq-traded companies, and serves on the Audit Committee and Compensation Committee of both companies. She also is on the Board of Directors of Omicia, Inc., an early-stage pharmaco-genomics company. She is Chairwoman of the BayBio Institute, a non-profit organization serving the Northern California life sciences industry by focusing on best practices, entrepreneurship, workforce development and science education, and also serves on the Board of Advisors to Astia, a non-profit organization dedicated to advancing women entrepreneurs. She also is on the Board of Advisors of the Professional Women’s Healthcare Alliance and of BioAgenda. She is a graduate of the Stanford Law School Board of Directors College course.
In 2003, she was included in Irish America magazine’s annual “Business 100” and received the Alumni Achievement Award from Marymount College at Fordham University in 2004.